WeVote

Bill

Bill

S 3356

Enacts the lab services accessibility act

2025 Regular Session Introduced by Gustavo Rivera and 1 co-sponsor

Summary of S 3356: Enacts the Lab Services Accessibility Act OverviewS 3356, the Lab Services Accessibility Act, is a bill that aims to improve access to clinical laboratory testin

DELIVERED TO ASSEMBLY
0
WeVote Research Nonpartisan
Bill Summary · S 3356

Summary of S 3356: Enacts the Lab Services Accessibility Act

Overview

S 3356, the Lab Services Accessibility Act, is a bill that aims to improve access to clinical laboratory testing services for individuals covered by Medicare and Medicaid. The bill was introduced in the Senate on January 27, 2025 and has been referred to the Committee on Health.

Key Provisions

The main elements of the Lab Services Accessibility Act include:

  1. Expanded Medicare/Medicaid Coverage: The bill would require Medicare and Medicaid to cover a wider range of lab services, including tests conducted at independent laboratories and mobile testing units. This would help ensure beneficiaries can access necessary lab work regardless of provider type.

  2. Reduced Patient Cost-Sharing: The legislation would eliminate deductibles, copays, and coinsurance for all lab tests covered by Medicare and Medicaid. This would make lab services more affordable and accessible for beneficiaries.

  3. Improved Transparency: Providers would be required to clearly disclose the costs of lab tests upfront, allowing patients to make informed decisions about their care. This provision is intended to increase price transparency in the lab testing industry.

  4. Expansion of In-Home/Mobile Testing: The bill directs the Centers for Medicare & Medicaid Services (CMS) to establish a program that would cover the costs of mobile lab testing services and in-home sample collection for Medicare and Medicaid enrollees. This could improve access for patients with mobility challenges or who live in underserved areas.

Potential Impact

If enacted, the Lab Services Accessibility Act could have several significant impacts:

  • Improved access to necessary lab tests for millions of Medicare and Medicaid beneficiaries, especially those with limited mobility or living in healthcare deserts.
  • Reduced financial barriers that currently prevent some patients from obtaining recommended lab work and screenings.
  • Increased transparency around lab test pricing, potentially driving down costs over time.
  • Expansion of innovative testing modalities like mobile units and in-home collection.

The bill aims to make lab services more affordable and available, which could lead to earlier detection of health issues and better health outcomes for the covered populations.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.